Salbutamol Inhalation for Cough with Hypothyroidism

Introduction to Salbutamol Use

• The American College of Chest Physicians explicitly states that albuterol (salbutamol) is not recommended for acute or chronic cough not due to asthma (Grade D recommendation) 1
• Salbutamol is indicated only for cough caused by asthma or bronchospasm, not for general cough suppression 1, 2

Diagnostic Considerations

• Before prescribing salbutamol, confirm reversible airflow obstruction through spirometry measuring lung function before and after bronchodilator administration 2
• If the patient has chronic cough, the British Thoracic Society recommends evaluating for post-nasal drip, gastroesophageal reflux, or other non-asthmatic causes first 4

Treatment Guidelines

• For asthma-related cough, salbutamol is appropriate at doses of 2.5-5 mg via nebulizer or 200-400 μg via hand-held inhaler 2, 3
• The primary concern in hypothyroid patients is cardiovascular: elderly patients or those with known/suspected heart disease should have their first salbutamol treatment supervised, as beta-agonists may rarely precipitate heart problems 3

Alternative Treatments

• First-line: Ipratropium bromide for cough suppression in non-asthmatic patients 1
• For chronic bronchitis: Central cough suppressants like codeine or dextromethorphan (Grade B recommendation) 1
• For upper airway cough: Intranasal steroids or antihistamine/decongestant combinations 4

Important Considerations

• Do not use salbutamol empirically for cough without establishing an asthma diagnosis, as this delays appropriate treatment of the actual cause 2
• Avoid using salbutamol as a diagnostic trial without objective evidence of bronchospasm—this is ineffective and delays proper diagnosis 2
• Do not rely on single peak expiratory flow measurements to assess bronchodilator response; use lung function tests instead 2